Top 10 Compounding Pharmacies for Tirzepatide (2026)

Last updated: August 2026 | Researched and written by the Newtropin Editorial Team

Tirzepatide is the highest-volume dual-agonist incretin therapy by prescription count, and demand for compounded versions grew rapidly during the period when the branded products were in shortage. That period has ended, which changed the compounding picture substantially — and a great deal of content still online has not caught up.

The Regulatory Position

Compounded tirzepatide was widely available under Section 503A while tirzepatide was listed on the FDA's drug shortage list. That listing is what permitted compounding of a drug that is otherwise "essentially a copy" of a commercially available product.

When the FDA declared the shortage resolved, that basis narrowed sharply. Compounding an essentially-a-copy preparation outside a shortage is generally not permitted, with limited exceptions where a prescriber documents a clinically significant difference for a specific patient — a genuinely narrow carve-out, not a general workaround.

What this means: pharmacies that lawfully compounded tirzepatide during the shortage may no longer be able to supply it in the same way. Operations still marketing it broadly warrant scrutiny about their basis for doing so. Our article on compounded tirzepatide legality and sourcing covers this in detail, and the tirzepatide peptide profile covers the pharmacology.

The rankings below assess pharmacies on capability and standards across incretin and metabolic compounding generally.

How We Selected These Pharmacies

Our editorial team evaluated compounding pharmacies against the criteria that actually differentiate quality in dual-agonist incretin and metabolic compounding:

• State licensing and 503A compliance — verified active licensure and adherence to Section 503A requirements
• USP 797 and 800 sterile compounding standards — clean-room classification, environmental monitoring, and aseptic technique validation
• Third-party analytical testing — potency, sterility, and endotoxin testing on dispensed lots
• Regulatory transparency — willingness to state clearly what may and may not be compounded under current FDA positions
• Provider support — prescriber education, dosing guidance, and dedicated account management
• Cold-chain logistics — validated temperature-controlled shipping for sensitive preparations
• Regulatory track record — inspection history, warning letters, and recall record

The Rankings

1. Newtropin

Known For: Provider-focused metabolic compounding partnership with active regulatory monitoring.

Key Strengths:

• Continuous FDA status monitoring across the incretin category, including shortage-list changes that alter what may be compounded
• Partnership with a licensed 503A compounding pharmacy under USP 797 and 800 standards
• Third-party analytical verification with certificates of analysis available to prescribers
• Validated cold-chain shipping nationwide
• Provider support including dosing references and dedicated account management

Notable: Our approach on incretins is to tell prescribing providers plainly where the current regulatory basis stands rather than to fill first and explain later. For metabolic protocols, our team works with providers on options with a clear regulatory footing.

2. Empower Pharmacy

Known For: High-volume sterile compounding with a broad metabolic formulary.

Key Strengths:

• Substantial sterile injectable capacity
• Established provider ordering infrastructure
• Broad metabolic and weight-management formulary

Notable: Confirm the current basis for any tirzepatide preparation directly with the pharmacy.

3. Hallandale Pharmacy

Known For: Sterile compounding with a large prescriber and telehealth network.

Key Strengths:

• Sterile injectable capability at scale
• Established clinic and telehealth relationships
• Metabolic formulary depth

Notable: Request analytical testing documentation for any injectable preparation.

4. LS Compounding

Known For: Peptide and metabolic compounding with third-party verification.

Key Strengths:

• Third-party laboratory testing on dispensed products
• Peptides and metabolic compounds as a primary category
• Rapid fulfillment for temperature-sensitive preparations

Notable: Verify current availability — this category has shifted repeatedly since the shortage resolution.

5. Olympia Pharmaceuticals

Known For: Broad sterile compounding across metabolic and wellness categories.

Key Strengths:

• Wide formulary across metabolic, hormone, and wellness preparations
• Nationwide distribution
• Provider-oriented ordering systems

Notable: Confirm cold-chain handling on any temperature-sensitive preparation.

6. Belmar Pharma Solutions

Known For: Hormone and metabolic compounding with clinical support emphasis.

Key Strengths:

• Long-standing compounding experience
• Prescriber education resources
• Individualized formulation capability

Notable: Useful where a documented clinically significant difference supports a customized preparation.

7. Strive Pharmacy

Known For: Personalized compounding with direct provider relationships.

Key Strengths:

• Individualized formulation focus
• Responsive prescriber communication
• Multi-state licensure

Notable: Confirm licensure covers your practice location.

8. Wells Pharmacy Network

Known For: Multi-facility compounding with a metabolic and wellness focus.

Key Strengths:

• Multiple compounding facilities
• Metabolic and wellness formulary
• Established ordering systems

Notable: Verify which facility fills your prescription and its accreditation.

9. Tailor Made Compounding

Known For: Peptide-centric compounder with telehealth integration.

Key Strengths:

• Large peptide and metabolic catalog
• ISO-classified clean-room sterile compounding
• Telehealth platform partnerships

Notable: Widely used by cash-pay metabolic clinics.

10. Innovation Compounding

Known For: Established compounder across hormone and metabolic categories.

Key Strengths:

• Hormone and metabolic formulary
• Provider consultation support
• Multi-state distribution

Notable: Confirm current incretin availability and its regulatory basis.

How to Evaluate Any Tirzepatide Source Now

Ask one question first: on what basis are you compounding this? Acceptable answers reference a documented clinically significant difference for the specific patient. Unacceptable answers are vague, reference a shortage that has been resolved, or avoid the question.

Then verify the standard items — state licensure, USP 797 compliance, third-party potency and sterility testing, certificates of analysis, and validated cold-chain shipping. Our guide to choosing a quality compounding pharmacy covers the full checklist.

Before You Choose

Accreditation and testing claims are verifiable — ask for them. A pharmacy that will provide a certificate of analysis, name its testing laboratory, and state its licensure clearly is telling you something meaningful about how it operates. Our guide to choosing a quality compounding pharmacy covers what to ask, and our FDA peptide status tracker tracks what is currently compoundable.

Newtropin is a nutraceutical and wellness marketing firm that connects healthcare providers with a licensed 503A compounding partner. We are not a pharmacy and do not compound or dispense.

Frequently Asked Questions

Is compounded tirzepatide still legal in 2026?

The broad basis for compounding it — tirzepatide's presence on the FDA drug shortage list — ended when the shortage was declared resolved. Compounding an essentially-a-copy preparation outside a shortage is generally not permitted, with a narrow exception where a prescriber documents a clinically significant difference for a specific patient.

Why did compounded tirzepatide become harder to get?

Compounding was permitted largely because of the shortage listing. Once the FDA declared the shortage resolved, that permission narrowed, and pharmacies that had been supplying it broadly generally could no longer do so on the same basis.

What is a "clinically significant difference"?

A documented, patient-specific clinical reason the commercially available product is unsuitable — for example an allergy to an inactive ingredient, or a dose that cannot be achieved with the commercial product. It is a narrow, documented exception, not a general workaround.

What should I ask a pharmacy offering compounded tirzepatide?

Ask directly what their current regulatory basis for compounding it is. Then verify state licensure, USP 797 compliance, third-party potency and sterility testing, and cold-chain shipping.

Is compounded tirzepatide the same as the brand product?

No. Compounded preparations are not FDA-approved products and are not evaluated for safety, efficacy, or manufacturing quality the way an approved product is. Concentration, excipients, and delivery format may all differ.

What are the alternatives?

FDA-approved tirzepatide products with approved indications are the clearest route where accessible. Our complete guide to semaglutide, tirzepatide, and retatrutide compares the options.